4.3 Article

Anti-inflammatory effect of a novel locally acting A(2A) receptor agonist in a rat model of oxazolone-induced colitis

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Experimental Models of Inflammatory Bowel Diseases

Patricia Kiesler et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)

Review Pharmacology & Pharmacy

Adenosine and inflammation: what's new on the horizon?

Luca Antonioli et al.

DRUG DISCOVERY TODAY (2014)

Article Hematology

Regulation of Neutrophil Function by Adenosine

Kathryn E. Barletta et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)

Review Pharmacology & Pharmacy

Pharmacological and therapeutic effects of A3 adenosine receptor agonists

Pnina Fishman et al.

DRUG DISCOVERY TODAY (2012)

Review Pharmacology & Pharmacy

Investigational A3 adenosine receptor targeting agents

Balazs Koscso et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)

Article Pharmacology & Pharmacy

The Blockade of Adenosine Deaminase Ameliorates Chronic Experimental Colitis through the Recruitment of Adenosine A2A and A3 Receptors

Luca Antonioli et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)

Article Gastroenterology & Hepatology

Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats

Hai-Qiang Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2009)

Article Infectious Diseases

An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models

Christopher C. Moore et al.

BMC INFECTIOUS DISEASES (2008)

Article Pharmacology & Pharmacy

Finding better therapeutic targets for patients with asthma: adenosine receptors?

R. Polosa

BRITISH JOURNAL OF PHARMACOLOGY (2008)

Article Biochemistry & Molecular Biology

Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis

Gabriela E. Garcia et al.

FASEB JOURNAL (2008)

Review Gastroenterology & Hepatology

Pharmacological modulation of adenosine system: Novel options for treatment of inflammatory bowel diseases

Luca Antonioli et al.

INFLAMMATORY BOWEL DISEASES (2008)

Review Biotechnology & Applied Microbiology

Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases

Gyorgy Hasko et al.

NATURE REVIEWS DRUG DISCOVERY (2008)

Review Pharmacology & Pharmacy

Regulation of enteric functions by adenosine: Pathophysiological and pharmacological implications

Luca Antonioli et al.

PHARMACOLOGY & THERAPEUTICS (2008)

Editorial Material Gastroenterology & Hepatology

Current view of the immunopathagenesis in inflammatory bowel disease and its implications fair therapy

M. I. Torres et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

Article Cell Biology

A2A receptors in inflammation and injury:: lessons learned from transgenic animals

Gyoergy Hasko et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2008)

Article Pharmacology & Pharmacy

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis

Luca Antonioli et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)

Article Physiology

Effect of adenosine A2A receptor activation in murine models of respiratory disorders

O Bonneau et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)

Article Critical Care Medicine

Adenosine A2A receptor activation reduces lung injury in trauma/hemorrhagic shock

G Haskó et al.

CRITICAL CARE MEDICINE (2006)

Article Pharmacology & Pharmacy

Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938

M Kuno et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2006)

Article Immunology

A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis

GW Sullivan et al.

JOURNAL OF INFECTIOUS DISEASES (2004)

Review Immunology

Adenosine: an endogenous regulator of innate immunity

G Hasko et al.

TRENDS IN IMMUNOLOGY (2004)

Article Physiology

Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis

S Adanin et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)

Article Pharmacology & Pharmacy

Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat

JR Fozard et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2002)